Optilume Drug-Coated Balloon for Urethral Strictures | Asklepios Hospital Barmbek Hamburg

The Asklepios Hospital Barmbek has established a new benchmark in reconstructive urology by integrating the Optilume drug-coated balloon into its treatment portfolio. For years, patients suffering from recurrent urethral strictures, painful narrowings caused by scar tissue, were trapped in a cycle of temporary dilations or faced the prospect of major reconstructive surgery. Optilume breaks this cycle by combining the immediate mechanical opening of the urethra with a localized pharmaceutical treatment. Our Hamburg-based specialists now offer this minimally invasive solution designed to stop scar tissue in its tracks, providing a definitive alternative for those seeking long-term relief without the downtime of open surgery. The "Optilume Effect" is a sophisticated two-phase process performed entirely through the urethra without a single external incision. In the first phase, a specialized high-pressure balloon is navigated to the stricture under high-definition endoscopic guidance. Upon inflation, it mechanically expands the narrowed passage to a healthy diameter. The second phase involves a breakthrough in targeted pharmacology. The balloon’s surface is coated with Paclitaxel, a medication that prevents cell overgrowth. As the balloon expands, it delivers this drug directly into the microfissures of the urethral wall. This targeted delivery inhibits the fibroblast cells responsible for creating scar tissue, effectively preventing the stricture from reforming. The intervention is remarkably swift, typically lasting between twenty and thirty minutes. Unlike traditional laser cutting (urethrotomy), which can trigger more scarring due to thermal damage, Optilume is a "cold" procedure. This approach preserves the integrity of the surrounding tissue and significantly reduces the risk of post-operative complications. For the patient, this means the primary cause of urinary obstruction is treated at the molecular level rather than just being physically pushed aside. The technical specifications at our Hamburg facility include a precise drug concentration of 3. 5 micrograms per square millimeter of Paclitaxel to optimize tissue absorption. The non-compliant, high-pressure PET balloon material enables precise sizing tailored to the patient's anatomy. We support treatment with comprehensive pre- and post-procedure uroflowmetry to objectively assess improvement in urinary stream. This technology is ideally suited for bulbar urethral strictures up to three centimeters in length, offering a science-driven alternative that respects the body’s natural healing process while preventing the return of obstructive scar tissue.